MedTrace Logo

Impact of Antioxidant Treatment on DNA Fragmentation Index

NCT03466229 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2018-03-16

No results posted yet for this study

Summary

Increased sperm DNA Fragmentation Index implies decreased male fertility in vivo and in vitro. There is need for developing new strategies for improvement of male fertility. The study aims to investigate whether high sperm DNA Integration Index can be treated by use of antioxidants.

Conditions

  • Male Infertility

Interventions

DIETARY_SUPPLEMENT

Androferti

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Q-Pharma

    collaborator UNKNOWN

  • Octean

    collaborator UNKNOWN

  • Region Skane

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-01
Primary Completion
2016-12-31
Completion
2016-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03466229 on ClinicalTrials.gov